A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease

Clinical trial NCT02564107 · COMPLETED

Trial details

NCT number: NCT02564107
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pain; Bone Neoplasms; Neoplasm Metastasis

Start date: 2004-11-01
Primary completion: 2006-04-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.